Thermo Fisher Scientific | TMO - Loan Capital


Thermo Fisher Scientific reported $39.18B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Agilent USD 3.64B 594M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 803M 100K Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Bruker USD 1.81B 151.8M Jun/2026
Charles River Laboratories USD 2.62B 43.15M Jun/2026
Danaher USD 25.15B 7.59B Jun/2026
Dentsply International USD 2B 10M Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
General Electric Aerospace USD 17.16B 1.02B Jun/2026
Henry Schein USD 2.3B 27M Jun/2026
Illumina USD 1.49B 1000K Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 13.7B 284M Jun/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Medtronic USD 25.62B 502M Jun/2026
Mettler Toledo International USD 2.04B 116.92M Jun/2026
Myriad Genetics USD 120.7M 400K Jun/2026
Olympus JPY 179.76B 20.07B Jun/2026
OraSure Technologies USD 100K 17K Dec/2025
Quest Diagnostics USD 5.63B 477M Jun/2026
Repligen USD 551.05M 4.46M Jun/2026
Revvity USD 2.63B 1.02M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Veracyte USD 0 0 Mar/2025
Waters USD 5.09B 129M Jun/2026
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026